U.S. To Keep Ebola-Exposed Citizens In Kenya Under New Policy
WEDNESDAY, May 27, 2026 — The Trump administration is reportedly preparing to send Ebola-exposed U.S. citizens to Kenya rather than bring them back to the…
GLP-1 Meds May Help Slow the Spread of Certain Obesity-Related Cancers
WEDNESDAY, May 27, 2026 — A new study suggests GLP-1 medications may slow the spread of certain obesity-related cancers. “GLP-1 receptor agonists have never been…
New drug could finally stop deadly fatty liver disease
Scientists at UC San Diego have unveiled a potentially game-changing treatment for MASH, a severe fatty liver disease affecting millions worldwide. The experimental drug, ION224,…
Trump Admin Bars Key U.S. Researchers From Global Virus Response Talk
TUESDAY, May 26, 2026 — The Trump administration has issued a directive shutting key U.S. health research officials out of global discussions on virus outbreaks,…
Scientists say they’ve reversed brain aging with a simple nasal spray
Researchers at Texas A&M have developed a nasal spray that appears to reverse brain aging by calming inflammation and restoring the brain’s energy systems. After…
Everyone Has A Family Doc, But Can You Get An Appointment?
Welcome to the first installment in HealthDay’s exclusive investigative series, “Is There A Doctor In The House? The U.S. Family Medicine Crisis.” Through original reporting,…
Many U.S. College Students With Psychosis Are Not Receiving Treatment
TUESDAY, May 26, 2026 — The college years are prime time for the emergence of mental illnesses involving psychosis, according to a new study. However,…
Antibiotics Won’t Help Ease Asthma-Linked Wheezing in Kids
TUESDAY, May 26, 2026 — Kids with asthma can have wheezing attacks severe enough to trigger a visit to the ER. However, a new trial…
Scientists discover why Ozempic and Wegovy weight loss eventually plateaus
New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same…
Common heart drug taken by millions found useless — and possibly dangerous
A massive international study could upend 40 years of heart attack treatment. Researchers found that beta blockers—routinely prescribed after uncomplicated heart attacks—offered no real benefit…